Gergely Bertalan1, Julia Onken2, Simone Schwedler3, Bernd Hamm1, Georg Bohner3, and Edzard Wiener3
1Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany, 2Neurosurgery, Charité - Universitätsmedizin Berlin, Berlin, Germany, 3Neuroradiology, Charité - Universitätsmedizin Berlin, Berlin, Germany
Synopsis
Conventional
MRI such as T2 and FLAIR do not show sub-regional intensity changes in
peritumoral infiltration zone of glioblastoma and cannot visualize tumor
margins. Here, we implemented a new method for sub-volumetric analysis
of glioblastoma and investigated T1 and T2 relaxation properties in the
peritumoral infiltration zone. The results show a decrease in T1 and T2
relaxation times as a function of distance from the contrast-enhanced T1 solid
tumor region to the periphery. Our method may help to better select regions
for biopsy, to determine the surgical resection margin and improve radiation
therapy planning and post-therapeutic progress controls.
Introduction
Glioblastoma
(GBM) is one of the most common and deadly brain tumors with a mean life
expectancy of only 12-15 months. Its main hallmarks are infiltrative growth and
lack of clear tumor boundaries [1]. Conventional MRI such as T1, T2 and FLAIR
do not show sub-regional intensity changes in peritumoral infiltration zone
(PI), making the definition of tumor volume for surgical resection and
radiation therapy challenging. Recently, it has been shown that T1 and T2
relaxometry can reveal distinct sub-regional differences which can be
correlated with tumor cell density of the infiltration zone [2,3,4,5,6].
However, during a conventional clinical MRI acquisition around two hundred
slices of two-dimensional (2D) images are produced per modality to represent
the three-dimensional (3D) brain volume. When multimodal dataset is acquired,
manual segmentation and quantitative analysis become time-consuming tasks.
Therefore, in the majority of cases only a couple of 2D slices are manually
segmented and quantitatively analyzed, which cannot depict the imaging
characteristics of the entire tumor volume and are highly influenced by the
selected slice positions. The aims of this study are (i) to implement a new
machine learning based segmentation method for volumetric analysis
of GBM and combine it with high spatial resolution quantitative MRI and (ii) to
test if T1 and T2 mapping show sub-volumetric changes around the tumor
core.Methods
Six patients with recurrent GBMs were investigated.
The study protocol (ethical application number EA1/306/16) conforms to the
ethical guidelines of the 1975 Declaration of Helsinki. MRI was performed on a
3 Tesla scanner (Vida; Siemens, Erlangen, Germany) using a 32-channel head coil
(Siemens, Erlangen, Germany). The clinical protocol consisted of pre-contrast
transversal 2D works-in-progress (WIP, Siemens, Erlangen, Germany) GRAPPATINI
T2 map with corresponding conventional T2, a 3D T2 dark fluid (T2-DF) and a
post-contrast 3D (WIP) MP2RAGE T1 map with corresponding post contrast T1
(T1c). Our new approach consisted of five steps: 1) image resampling and
registration, 2) skull stripping, 3) GBM segmentation, 4) division of PI into
concentric sub-volumes around the contrast-enhanced T1 tumor core and 5)
statistical analysis of the volumes. All images were resampled to a uniform
256×256×220 matrix size and 1mm isotropic resolution and co-registered to the
T1c volume by Nibabel3.2 [7]. Skull-striping was done automatically before
segmentation by a self-trained standard U-Net model [8]. GBM was segmented into
enhancing T1 tumor core (TC), non-enhancing necrotic tumor (NT) and peritumoral
infiltration zone (PI) by a modified version of
the U-Net model. The model was self-trained on transversal images in a slice-wise
fashion in 2D using three contrasts for each slice position: T1c, T2-DF and T2.
After automatic segmentation, the created segments were corrected by an
experienced neuro-radiologist. At the end, the whole PI was divided into 10
concentric one-pixel-width
sub-volumes around the tumor core using a self-implemented discrete 3D region
growth algorithm.Results
Figure 1 shows example
images of our clinical protocol from one patient. Figure 2 shows generated and
corrected tumor segments overlaid on T1c and T2-DF for the slice positions
showed in Figure 1. Corresponding 3D segments of TC, NT and PI for the entire
tumor volume are shown in Figure 3. Figure 4a shows on a 2D transversal slice
examples of ten generated, one-pixel-width sub-regions of PI, concentrated
around the tumor core with increasing distance from it. Figure 4b shows the
entire volume of TC and the corresponding first and fourth concentric
sub-volumes of PI in 3D. Figure 5a shows volumetric T1 and T2 relaxation times in the generated
sub-volumes of PI in six patients, while Figure 5b shows the corresponding
group mean values. Within ca. 10mm from TC (from 2nd to 10th
sub-volume), T1 and T2 relaxation times decreased by 9.3% (T1: 2nd
sub-volume 1536ms vs. 10th sub-volume 1405ms) and 12.6% (T2: 2nd
sub-volume 1755ms vs. 10th sub-volume 1559ms), respectively.Discussion
To our knowledge, this is the first 3D volumetric evaluation of T1 and T2
relaxation times in peritumoral
infiltration zone. We found significant decrease in T1 and T2
relaxation times from the neighboring to the peripheral edema regions of GBM.
Peritumoral edema in GBM is a mixture of healthy brain parenchyma and tumor
cell infiltration zone [9,10]. Edema is mainly caused by vascularization,
micro-necrosis, angiogenesis and apoptosis, effects which are higher in the
close proximity of the tumor core than at greater distance from it [9,10]. The
decay of T1 and T2 relaxation values from tumor core toward the edema periphery
might be accountable for changes in tumor cell density and corresponding
alteration of the extracellular matrix [3,4,6], as GBM always shows an
infiltrative growth and tumor cell migration from the inside out [9,10].Conclusion
Volumetric 3D analysis
of T1 and T2 relaxation times reveals marked differences in the sub-volumes of peritumoral infiltration zone around the contrast-enhanced T1
tumor region in glioblastomas, indicating tissue alteration due to tumor cell
migration that can be detected by quantitative MRI. The method presented here
may help to better select regions for biopsy prior to surgical resection and to
better plan the resection margin and radiation therapy field.Acknowledgements
Works-in-progress
(WIP, Siemens, Erlangen, Germany) sequences (GRAPPATINI T2 mapping and
compressed sensing MP2RAGE) from Siemens Healthineers, which made
time-efficient measurements of T1 and T2 mapping in clinical setup possible, are
gratefully acknowledged.References
1. Delgado-López PD, Corrales-García EM. Survival in
glioblastoma: a review on the impact of treatment modalities. Clin
Transl Oncol. 2016;18(11):1062-1071.
2. Nöth U, Tichy J, Tritt S, Bähr O, Deichmann R, Hattingen
E. Quantitative T1 mapping indicates tumor infiltration beyond the enhancing
part of glioblastomas. NMR Biomed. 2020;33(3):e4242.
3. Kern M, Auer TA, Picht T, Misch M, Wiener E. T2
mapping of molecular subtypes of WHO grade II/III gliomas. BMC Neurol.
2020;20(1):8.
4. Auer TA, Kern M, Fehrenbach U, Tanyldizi Y, Misch M,
Wiener E. T2 mapping of the peritumoral infiltration zone of glioblastoma and
anaplastic astrocytoma. Neuroradiol J. 2021;34(5):392-400.
5. Blystad I, Warntjes JBM, Smedby Ö, Lundberg P, Larsson
EM, Tisell A. Quantitative MRI for analysis of peritumoral edema in malignant
gliomas. PLoS One. 2017;12(5):e0177135.
6. Blystad I, Warntjes JBM, Smedby Ö, Lundberg P, Larsson
EM, Tisell A. Quantitative MRI using relaxometry in malignant gliomas detects
contrast enhancement in peritumoral oedema. Sci Rep.
2020;10(1):17986.
7. Matthew
Brett (MB), Chris Markiewicz (CM), Michael Hanke (MH), Marc-Alexandre Côté
(MC), Ben Cipollini (BC), Paul McCarthy (PM), Chris Cheng (CC), Yaroslav
Halchenko (YOH), Satra Ghosh (SG), Eric Larson (EL), Demian Wassermann, Stephan
Gerhard and Ross Markello (RM): NiBabel; https: www.nipy.org/nibabel/
8. Ronneberger,
Olaf; Fischer, Philipp; Brox, Thomas (2015). "U-Net: Convolutional
Networks for Biomedical Image Segmentation". arXiv:1505.04597
9. Urbańska K, Sokołowska J, Szmidt M, Sysa P.
Glioblastoma multiforme - an overview. Contemp Oncol (Pozn).
2014;18(5):307-312.
10. Chang PD, Malone HR, Bowden SG, et al. A
Multiparametric Model for Mapping Cellularity in Glioblastoma Using Radiographically
Localized Biopsies. AJNR Am J Neuroradiol.
2017;38(5):890-898.